The Clinical Trial Company Limited Celebrates 10th Year Anniversary
Published: Apr 26, 2012
During the past 10 years TCTC has become a renowned contract research organization and leading provider for clinical development of products which do not have a classical road map to approval, including advanced therapies and orphan drug indications. With operations reaching as far as Europe, North America and Australia, TCTC, an ISO 9001:2008 certified company, has grown to provide a high quality bespoke service.
The continuous delivery of a quality and professional service has earned TCTC a reputation for expertise in an extensive range of clinical trial therapeutic areas and phases. TCTC is proud to have a wide variety of clients from Pharmaceutical companies who rank among the largest in the world to start up Biotechnology clients who have a little as 2 employees.
The TCTC motto of 'Treat every client as if they are our only client' and the dedication and professionalism of our teams has allowed TCTC to develop a loyal and ever growing customer base over the past decade. TCTC has grown organically since its inception and now has dedicated Regulatory and Clinical Quality Assurance consultancies amongst its 5 divisions. The group continues with its bold growth plans such as new market expansion in India and China and new products such as training services for the Drug Industry through its The CLINICAL TRAINING Company division.
Kerri Leeming, Clinical Operations Director and founder of TCTC reflects: "Ten years in business marks an important milestone for the company particularly in the current economic climate. From a single office and two staff, we have grown to have offices in America, Europe and Australia. After a decade of hard work and perseverance we are proud of where we are today and will continue to dedicate our passion to this industry."
“We sincerely appreciate our customers, suppliers and partners support, without which we would not have grown as we have over the last 10 years. We are also very proud of the professionalism and dedication of our staff worldwide who have shared our positive attitude and sense of urgency with our customers." affirmed Ewan Campbell, Director of TCTC.
For further enquiries:
Ewan Campbell, Director Tel: +44 1565 733772
Marc Renaud, Director Tel: + 1 438 257 1161
About The Clinical Trial Company:
The Clinical Trial Company was incorporated in 2002. The TCTC founders realised an opportunity existed within the CRO sector for a company targeting medium size clinical trials and innovative products which lacked a classical road map to the market. Large CROs prioritise studies from the big pharmaceutical companies, for good business reasons. However, this approach sometimes disadvantages their smaller clients who are equally keen to complete their clinical trials quickly. TCTC specializes in advanced therapy drugs such as cell & gene therapy as well as first in class biotechnology products. These types of investigational drugs often do not follow the classical road map to approval. They are also often Orphan Drugs which are targeted at meeting the unmet clinical needs of rare diseases.
TCTC has an experienced management team that offers extensive experience working with the EMA, FDA and MHRA to all their clients. Customer satisfaction is the key to our success as we always aim to provide our clients with efficient resource management and an alternative to conventional off-the-shelf approval strategies which ignore the unique nature of each product and market.
The TCTC has its headquarters in Knutsford, Cheshire (UK) with additional offices in Cambridge (UK), Berlin (Germany), Toronto and Montreal (Canada), as well as Sydney (Australia). TCTC has operating divisions covering all aspects of drug development which include The CRA Company, The Regulatory Affairs Company, The Clinical Training Company and The CQA Company.
Additional information about TCTC can be found at www.theclinicaltrialcompany.com